Matteo Pirro
Impact in
- Molecular Medicine top 0.5%
- Curcumin's Biomedical Applications
-
- Cardiovascular Health and Disease Prevention
- Blood Pressure and Hypertension Studies
Papers in
-
- Cardiovascular Health and Disease Prevention 34
- Blood Pressure and Hypertension Studies 23
-
- Diabetes, Cardiovascular Risks, and Lipoproteins 35
- Co-authors
- Amirhossein SahebkarElmo MannarinoVanessa BianconiMassimo R. MannarinoGiuseppe SchillaciMaciej BanachGaetano VaudoFrancesco Bagaglia
In The Last Decade
Matteo Pirro
257 papers receiving 11.0k citations
Hit Papers
Peers
Comparison fields: 5 of 160
- Molecular Medicine 936
- Cardiology and Cardiovascular Medicine 2.3k
- Endocrinology, Diabetes and Metabolism 1.6k
- Immunology 1.7k
- Cancer Research 1.1k
Countries citing papers authored by Matteo Pirro
This map shows the geographic impact of Matteo Pirro's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Matteo Pirro with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Matteo Pirro more than expected).
Fields of papers citing papers by Matteo Pirro
This network shows the impact of papers produced by Matteo Pirro. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Matteo Pirro. The network helps show where Matteo Pirro may publish in the future.
Co-authors
The 25 scholars most cited alongside Matteo Pirro, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 1 | |
| 2 | 2025 | 1 | |
| 3 | 2025 | 1 | |
| 4 | 2024 | 3 | |
| 5 | 2023 | 4 | |
| 6 | 2023 | 13 | |
| 7 | 2023 | 2 | |
| 8 | 2022 | 3 | |
| 9 | 2019 | 42 | |
| 10 | 2018 | 13 | |
| 11 | 2018 | 18 | |
| 12 | 2017 | 61 | |
| 13 | 2017 | 19 | |
| 14 | 2007 | 67 | |
| 15 | 2007 | 90 | |
| 16 | 2005 | 40 | |
| 17 | 2005 | 58 | |
| 18 | 2004 | 2 | |
| 19 | 2003 | 6 | |
| 20 | 2003 | 27 |
About Matteo Pirro
Matteo Pirro is a scholar working on Cardiology and Cardiovascular Medicine, Endocrinology, Diabetes and Metabolism, Molecular Medicine, Cancer Research and Surgery, having authored 263 papers that have together received 11.2k indexed citations. Recurring topics across this work include Lipoproteins and Cardiovascular Health (65 papers), Diabetes, Cardiovascular Risks, and Lipoproteins (35 papers), Cardiovascular Health and Disease Prevention (34 papers), Adipokines, Inflammation, and Metabolic Diseases (24 papers), Blood Pressure and Hypertension Studies (23 papers), Cancer, Lipids, and Metabolism (23 papers), Atherosclerosis and Cardiovascular Diseases (17 papers) and Cholesterol and Lipid Metabolism (15 papers). The work is most often cited by research in Molecular Medicine (936 citations), Cardiology and Cardiovascular Medicine (2.3k citations), Endocrinology, Diabetes and Metabolism (1.6k citations), Immunology (1.7k citations) and Cancer Research (1.1k citations). Matteo Pirro has collaborated with scholars based in Italy, Iran and Poland. Frequent co-authors include Amirhossein Sahebkar, Elmo Mannarino, Vanessa Bianconi, Massimo R. Mannarino, Giuseppe Schillaci, Maciej Banach, Gaetano Vaudo, Francesco Bagaglia, Thomas P. Johnston and Muhammed Majeed. Their work appears in journals such as Atherosclerosis, Nutrition Metabolism and Cardiovascular Diseases, Pharmacological Research, Metabolism and Hypertension.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.